Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

GeneDx Holdings Corp. - Class A Common Stock (NQ:WGS)

140.17 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EST, Dec 22, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 6
Open 140.17
Bid (Size) 130.01 (100)
Ask (Size) 144.99 (100)
Prev. Close 140.17
Today's Range 140.17 - 140.17
52wk Range 55.17 - 170.87
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
The Great Rotation: Small-Caps Break All-Time Highs as Investors Pivot from Mega-Tech
NEW YORK — In a dramatic shift that has redefined the market landscape of 2025, small-cap stocks have surged to historic levels, signaling what many analysts are calling the "Great Rotation." On... 
Via MarketMinute
Topics Artificial Intelligence Economy Initial Public Offering
News headline image
The Great Rotation: Why the Russell 2000 is Finally Outpacing the Giants in Late 2025
As of mid-December 2025, the long-awaited "Great Rotation" in the financial markets has shifted from a theoretical prediction to a dominant reality. For the better part of the last three years,... 
Via MarketMinute
Topics Artificial Intelligence Bonds Economy

Performance

YTD
+76.0%
+76.0%
1 Month
-13.0%
-13.0%
3 Month
+8.0%
+8.0%
6 Month
+75.8%
+75.8%
1 Year
+83.5%
+83.5%

More News

Read More
News headline image
Earnings Scheduled For October 28, 2025 ↗
Via Benzinga
News headline image
GeneDx Hldgs's Earnings: A Preview ↗
Via Benzinga
News headline image
GeneDx Holdings Corp. (NASDAQ:WGS) Passes Minervini Trend Template and High-Growth Momentum Screen ↗
Via Chartmill
News headline image
JAMA (Journal of the American Medical Association) Recognizes GUARDIAN Newborn Genomic Screening Study Among Its Research of the Year
From GeneDx
Via Business Wire
News headline image
GeneDX CEO Sells 2,158 Shares After 84% One-Year Bump ↗
Via The Motley Fool
Topics Artificial Intelligence Regulatory Compliance
News headline image
Option Care Health Bring Home Hefty Share Price Gains; Earns RS Rating Upgrade ↗
Via Investor's Business Daily
News headline image
GeneDx Holdings Corp (NASDAQ:WGS) Presents a Strong Case for Growth Momentum and Technical Breakout ↗
Via Chartmill
News headline image
Is Teladoc Stock a Buy After Oracle Investment Management Upped Its Stake? ↗
Via The Motley Fool
News headline image
6 Healthcare Stocks With Strong Upward Momentum ↗
Via Benzinga
News headline image
BOSUN Sells All 70K GeneDx Holdings Corp. Shares—Should Investors Follow Suit? ↗
Via The Motley Fool
Topics Artificial Intelligence
News headline image
BOSUN Sells All 70K GeneDx Holdings Corp. Shares—Should Investors Follow Suit? ↗
Via The Motley Fool
Topics Artificial Intelligence
News headline image
Artificial Intelligence (AI) Stock Scores Vote of Confidence From Asset Manager, According to Recent Filing ↗
Via The Motley Fool
Topics Artificial Intelligence Regulatory Compliance
News headline image
GeneDx to Showcase Advancements in Gene-Disease Discovery, Long-Read Sequencing and More at National Society of Genetic Counselors (NSGC) 2025 Annual Meeting
From GeneDx
Via Business Wire
News headline image
GeneDx Holdings Corp (NASDAQ:WGS) Emerges as a Premier Growth and Momentum Stock ↗
Via Chartmill
News headline image
GeneDx to Participate in Upcoming Investor Conferences
From GeneDx
Via Business Wire
News headline image
What Does the Market Think About GeneDx Holdings Corp? ↗
Via Benzinga
News headline image
GeneDx (WGS) Q3 2025 Earnings Call Transcript ↗
Via The Motley Fool
Topics Earnings
News headline image
GeneDx Holdings Corp (NASDAQ:WGS) Q3 2025 Earnings Beat Estimates and Drive Stock Higher ↗
Via Chartmill
Topics Earnings
News headline image
GeneDx Reports Third Quarter 2025 Financial Results and Business Highlights
From GeneDx
Via Business Wire
News headline image
Halper Sadeh LLC Encourages GeneDx Holdings Corp. Shareholders to Contact the Firm to Discuss Their Rights
From Halper Sadeh LLC
Via Business Wire
News headline image
GeneDx Showcases Leadership in Genomic Newborn Screening at ICoNS 2025
From GeneDx
Via Business Wire
News headline image
4 Analysts Assess GeneDx Holdings: What You Need To Know ↗
Via Benzinga
News headline image
GeneDx Granted FDA Breakthrough Device Designation for its ExomeDx™ and GenomeDx™ Testing
From GeneDx
Via Business Wire

Frequently Asked Questions

Is GeneDx Holdings Corp. - Class A Common Stock publicly traded?
Yes, GeneDx Holdings Corp. - Class A Common Stock is publicly traded.
What exchange does GeneDx Holdings Corp. - Class A Common Stock trade on?
GeneDx Holdings Corp. - Class A Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for GeneDx Holdings Corp. - Class A Common Stock?
The ticker symbol for GeneDx Holdings Corp. - Class A Common Stock is WGS on the Nasdaq Stock Market
What is the current price of GeneDx Holdings Corp. - Class A Common Stock?
The current price of GeneDx Holdings Corp. - Class A Common Stock is 140.17
When was GeneDx Holdings Corp. - Class A Common Stock last traded?
The last trade of GeneDx Holdings Corp. - Class A Common Stock was at 12/22/25 04:00 PM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.